Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

Healthcare Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Medipharm Labs Corp > Sorry, im new to Labs...
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(5)
•••
Comment by Lemoyneon Nov 21, 2020 8:31pm
219 Views
Post# 31947959

RE:RE:Sorry, im new to Labs...

RE:RE:Sorry, im new to Labs...As much as I think LABS will improve over long term, principally due to german/STADA, Australia and other pharma deals, I think next year will disappoint people hoping for a quick buck or people that got in during 2019 high.

Reality is, german medical market is not even worth 300M USD, maybe not even 250M USD in 2020. Considering this, it is not realistic to expect LABS making huge money next year from STADA deal. I'd consider LABS off to a good start making 15-20M from STADA deal in first year, with most of it made in second half 2021. I would expect this to hike up to 100-150M per year in 2025 from STADA deal only.

This is a good spot to start entering for sure though, keeping money to enter later if stock drops before Q1 2021.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities